Deals
SRX Global Agrees to Buy Cell Therapy Developer CERo Therapeutics
A special purpose vehicle, CERO 1236, will raise money directly into the subsidiary so existing SRX shareholders are not diluted, the company said.
KCSA Strategic Communications
Deals
A special purpose vehicle, CERO 1236, will raise money directly into the subsidiary so existing SRX shareholders are not diluted, the company said.